Boston Scientific (Brazil) Top Management
B1SX34 Stock | BRL 554.58 11.78 2.17% |
Boston Scientific employs about 10 people. The company is managed by 10 executives with a total tenure of roughly 24 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Boston Scientific's management performance can provide insight into the company performance.
Jodi Eddy Insider VP Officer |
Vance Brown Insider Gen VP |
Boston |
Boston Scientific Management Team Effectiveness
The company has return on total asset (ROA) of 0.0425 % which means that it generated a profit of $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0407 %, meaning that it generated $0.0407 on every $100 dollars invested by stockholders. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities.Boston Scientific Workforce Comparison
Boston Scientific is number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is currently estimated at about 645,543. Boston Scientific adds roughly 10.0 in number of employees claiming only tiny portion of all equities under Medical Devices industry.
The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17. Boston Scientific Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Boston Scientific Price Series Summation is a cross summation of Boston Scientific price series and its benchmark/peer.
Boston Scientific Notable Stakeholders
A Boston Scientific stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Boston Scientific often face trade-offs trying to please all of them. Boston Scientific's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Boston Scientific's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jodi Eddy | VP Officer | Profile | |
Vance Brown | Gen VP | Profile | |
Catherine Jennings | VP Interventions | Profile | |
Joseph Fitzgerald | Ex Cardiology | Profile | |
John Sorenson | Ex Operations | Profile | |
Daniel Brennan | Ex CFO | Profile | |
Jeffrey Mirviss | Ex Interventions | Profile | |
Michael Mahoney | Pres Chairman | Profile | |
Jonathan Monson | Global VP | Profile | |
Susan Lisa | VP Relations | Profile |
About Boston Scientific Management Performance
The success or failure of an entity such as Boston Scientific often depends on how effective the management is. Boston Scientific management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Boston management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Boston management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. BOSTON SCIENDRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 41000 people.
Please note, the presentation of Boston Scientific's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Boston Scientific's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Boston Scientific's management manipulating its earnings.
Boston Scientific Workforce Analysis
Traditionally, organizations such as Boston Scientific use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Boston Scientific within its industry.Boston Scientific Manpower Efficiency
Return on Boston Scientific Manpower
Revenue Per Employee | 1.2B | |
Revenue Per Executive | 1.2B | |
Net Income Per Employee | 104.1M | |
Net Income Per Executive | 104.1M |
Complementary Tools for Boston Stock analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |